Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Skin treatment can lower life quality for patients with skin conditions.

Careful planning and skilled surgery can make hair replacement safe and effective.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Low iron and vitamin D levels are linked to hair loss in women.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Hair follicles help attract immune cells to the skin during stress.

Testosterone may influence COVID-19 severity and outcomes.

A woman experienced fluctuating thyroid conditions and eye disease, but her symptoms improved with treatment.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.